Secondary cytoreductive surgery in epithelial ovarian cancer: Nonresponders to first-line therapy
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 33 (1) , 1-5
- https://doi.org/10.1016/0090-8258(89)90593-3
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Aggressive regional surgery for advanced ovarian carcinomaCancer, 1986
- Second-look laparotomy in ovarian cancer: Evaluation of pathologic variablesAmerican Journal of Obstetrics and Gynecology, 1985
- The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgeryBJOG: An International Journal of Obstetrics and Gynaecology, 1985
- Stage III epithelial ovarian cancer: The role of maximal surgical reductionGynecologic Oncology, 1984
- A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancerGynecologic Oncology, 1983
- PRIMARY CYTOREDUCTIVE SURGERY FOR EPITHELIAL OVARIAN-CANCER1983
- SURVIVAL OF PATIENTS FOLLOWING SECONDARY CYTOREDUCTIVE SURGERY IN OVARIAN-CANCER1983
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- The changing prognosis and treatment in cancer of the ovaryAmerican Journal of Obstetrics and Gynecology, 1968